3.6 million Medicare enrollees may now be eligible for Wegovy coverage
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 billion a year and contribute to higher Part D premiums for all beneficiaries.
← Back to stories
National6 articles from 6 sources across the spectrum· Updated 889d ago
4 across the spectrum · tap a section to jump
Left
3 viewpoints3.6 million Medicare enrollees may now be eligible for Wegovy coverage
FDA approval of Wegovy could give millions on Medicare access to weight-loss drug
A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity
Center
1 viewpointRan by 3 outlets across the spectrum· WMUR, Local News 8
Right
0 viewpointsNo Right coverage yet.
A blind spot on this side of the story.